Abstract

To study the tuberculosis (TB) trends in the Russian Federation for 2010-2019 and 2020. Methods. The main epidemiological TB indicators, including TB-HIV co-infection and multidrugresistant tuberculosis (MDR-TB) for 2010-2019 and 2020 were calculated. Results. The estimate number of TB deaths in 2015-2020 went down by at least 58.7%. The absolute number of incident TB cases (new cases and relapses) decreased by 32.5% in 2015-2020. By quarter’s I-III of 2020, the rates of primary MDR-TB increased up to 33.7%. Since 2016, the incidence of TB and HIV co-infection has been stable. The prevalence of TB has been continuously decreasing, and during the past 2-3 years, a decrease in the prevalence of TB- HIV co-infection and MDR-TB was reported. Conclusion. Russia has achieved the interim results of the End TB Strategy 2020, as well as the level of TB incidence corresponding to the late Soviet time. The growth of MDR-TB rate shows the need to expand the introduction of innovative anti-tuberculosis drugs and to revise the regimens for prevention of latent TB infection.

Highlights

  • Russia has achieved the interim results of the End TB Strategy 2020

  • well as the level of TB incidence corresponding to the late Soviet time

  • The growth of multidrugresistant tuberculosis (MDR-TB) rate shows the need to expand the introduction of innovative anti-tuberculosis drugs

Read more

Summary

Introduction

Prevalența TBC a scăzut continuu și, în ultimii 2-3 ani, s-a raportat o scădere a prevalenței co-infecției TB-HIV și a TB- MDR. Первичную регистрируемую заболеваемость ТБ рассчитывали, как отношение числа больных ТБ к среднегодовой численности населения. Частоту рецидивов ТБ оценивали, как отношение числа зарегистрированных больных с рецидивом ТБ к среднегодовой численности населения.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.